Rating: BUY
BUY (5-tier) · mature cash generator · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $216 |
| Triangulated Fair Value | $199 (-8% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $249 (+15% vs spot · 12m PWEV) |
| Forward P/E | 44.2x |
| Market Cap | $296B |
| 52-Week Range | $83–$270 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | BUY · BUY (5-tier) |
| Classification · conviction | mature cash generator · medium |
| Triangulated fair value | $199 (-8% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $249 (+15% vs spot · 12m PWEV) |
| Next catalyst | 2026-06-16 — Investor Day - long-term WFE / process-control-intensity and margin targets |
| Primary thesis-break | Quarterly revenue year-on-year growth < -0.05 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = BUY because:
- Probability-weighted scenario value implies +15% vs spot
- Monte Carlo median implies +4% vs spot
- DCF fair value implies -34% vs spot — but this is terminal-value sensitive (exit-multiple $144 vs Gordon $76, 47% apart), so it carries less weight
- Bear case (Structural — WFE Reset / China Restriction) downside is -68% vs spot
- Net: reward/risk of 0.1× supports a Buy.
Investment Thesis
At $301.71 KLAC trades near 62 times forward earnings and about 26 times enterprise value to revenue, a valuation that prices process control as a secular winner insulated from the wafer-fab-equipment cycle. The engine disputes that framing. Our probability-weighted target of $249.90 sits 17% below spot because the multiple, not the earnings, carries the story: the variance decomposition attributes 82% of outcome dispersion to the P/E and only 13% to revenue growth. Segment economics anchor a base earnings power near $4.87, consistent with the Monte Carlo median of $4.90, but the market's implied multiple leaves little room if WFE normalises rather than re-rates. We weight a semi-downturn state at 37% and assign a fifth of probability to structural impairment from a China-restriction shock, whose target sits below the 52-week low by construction. The rating is HOLD: earnings are durable, but the price already discounts the upcycle. The single most damaging risk is a synchronised de-rating and order air-pocket, where a compressing multiple meets falling revenue at the same time.
The dashboard below is the whole argument on one page: spot ($216) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The steelman for the highest-probability bear, the semi-downturn state at 37%, runs through order timing, not franchise quality. Process control is genuinely advantaged, but KLAC still sells capital equipment into a cyclical WFE budget that customers cut first when utilisation falls. A digestion phase after two years of AI-driven capex, layered on tighter China export controls that remove a chunk of addressable demand, produces the capex-cut mechanism: bookings roll below parity, revenue contracts low-double-digits, and fixed-cost deleverage takes the operating margin back several points. At 55-plus times earnings, even a modest earnings miss is amplified by multiple compression, because the rating priced permanence. The result is a target near the cyclical or structural cases, not the base.
Key Debate
P/E Multiple explains 82% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.46 vs analyst floor +0.25 → delta +0.21 (n=25 mgmt / 22 Q&A; 15th pctile across the S&P book, z -1.1).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.46 | +0.25 | +0.21 |
| 2026Q1 | +0.46 | +0.12 | +0.34 |
| 2025Q4 | +0.58 | +0.51 | +0.07 |
| 2025Q3 | +0.39 | +0.19 | +0.20 |
News (last 365d, 1000 articles): avg ticker sentiment +0.19 (bullish 29% / bearish 6%)
Scenario Analysis
The tree runs from a structural 'Structural — WFE Reset / China Restriction' downside ($70) to a 'Bull — Supercycle Re-Rate' bull case ($457); the probability-weighted blend (PWEV $249) is +15% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — WFE Reset / China Restriction | 20% | $70 | -68% |
| Cyclical Downturn — Capex Cut | 17% | $189 | -13% |
| Base — Normalised WFE | 35% | $268 | +24% |
| Upcycle — Leading-Edge / HBM Capex | 20% | $362 | +67% |
| Bull — Supercycle Re-Rate | 8% | $457 | +111% |
| Probability-Weighted (PWEV) | — | $249 | +15% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — WFE Reset / China Restriction (20%, $70). Structural impairment — WFE reset / China restriction: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 70.44; probability: 0.2.
- Cyclical Downturn — Capex Cut (17%, $189). Cyclical downturn — wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions weakens for 1–2 years before normalising. Drivers — implied_target: 193.2; probability: 0.17.
- Base — Normalised WFE (35%, $268). Mid-cycle — normalised wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions; disciplined capital allocation; steady returns. Drivers — implied_target: 268.33; probability: 0.35.
- Upcycle — Leading-Edge / HBM Capex (20%, $362). Upside — leading-edge + HBM capex lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 362.25; probability: 0.2.
- Bull — Supercycle Re-Rate (8%, $457). Upside tail — sustained tight conditions or a structural re-rate on leading-edge + HBM capex. Drivers — implied_target: 457.51; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $224 | +4% |
| Peer P/E re-rate | multiple | $233 | +8% |
| Peer EV/Revenue re-rate | multiple | $151 | -30% |
| Scenario PWEV | multiple | $249 | +15% |
| DCF (5-year + terminal) | cash flow + terminal × | $144 | -34% |
| Triangulated (weighted) | — | $199 | -8% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $224 and 53% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (82% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 10.0%, 30x terminal FCF multiple → $144. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 47.62x) implies $233. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 47% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Semiconductor Equipment | $13.1B | 100% | 8% | 55% | $7.3B | 51x | 4% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions |
| net_debt_or_cash_b | -4.36 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.0032 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | WFE reset / China restriction |
| upside | leading-edge + HBM capex |
Industry Context — Information Technology — Semis
This name sits in the Information Technology — Semis as a semi_equipment. wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: AVGO (semiconductors) · AMD (semiconductors) · INTC (semiconductors) · AMAT (semi_equipment) · KLAC (semi_equipment) · TXN (semiconductors) · MRVL (semiconductors) · QCOM (semiconductors) · ADI (semiconductors) · NXPI (semiconductors) · MPWR (semiconductors) · TER (semi_equipment) · MCHP (semiconductors) · ON (semiconductors) · Q (semi_equipment) · SWKS (semiconductors)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Semi Downturn — AI-Capex Digestion / China | 37% | 37% | |
| Mid-Cycle — Normalised + AI Content | 35% | 35% | |
| Upcycle — AI / Datacenter Supercycle | 28% | 28% |
Mapping note: name-level 'Structural — WFE Reset / China Restriction' (20%) + 'Cyclical Downturn — Capex Cut' (17%) map to cluster Semi Downturn — AI-Capex Digestion / China (37%); name-level 'Upcycle — Leading-Edge / HBM Capex' (20%) + 'Bull — Supercycle Re-Rate' (8%) map to cluster Upcycle — AI / Datacenter Supercycle (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Semi Downturn — AI-Capex Digestion / China () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The it_semis cycle is the shared macro driver. Driver — chip demand (AI/datacenter, auto, mobile) + semi cycle + WFE capex + China/export controls Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $14B | $8B | $0B | $0B | $7B | $6B |
| FY+2 | $15B | $9B | $0B | $0B | $8B | $6B |
| FY+3 | $16B | $10B | $0B | $0B | $8B | $6B |
| FY+4 | $17B | $10B | $0B | $0B | $9B | $6B |
| FY+5 | $18B | $11B | $1B | $0B | $9B | $6B |
| Terminal | — | — | — | — | $9B × 30x | $170B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 10.0% · Σ PV(FCF) $31B + PV(terminal) $170B = EV $201B; + net cash → equity $197B ÷ diluted shares 1.37B = $144/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $76/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 94% vs WACC 10% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| LRCX | 21.57x | 47.62x | 8% | 35% |
| AMAT | 16.08x | 49.26x | 8% | 32% |
| Q | 7.35x | 40.32x | 8% | 23% |
| Median | 16.08x | 47.62x | — | — |
Peer-median fwd P/E → $233; EV/Rev → $151.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $144 | 41% | $59 |
| Scenario PWEV | $249 | 29% | $73 |
| Monte Carlo median | $224 | 18% | $40 |
| Peer P/E | $233 | 12% | $27 |
| Triangulated | — | 100% | $199 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 21.0x | 25.5x | 30.0x | 34.5x | 39.0x |
|---|---|---|---|---|---|
| 8% | $116 | $137 | $157 | $177 | $198 |
| 9% | $111 | $131 | $150 | $170 | $189 |
| 10% | $106 | $125 | $144 | $162 | $181 |
| 11% | $102 | $120 | $138 | $156 | $173 |
| 12% | $98 | $115 | $132 | $149 | $166 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $119 | $122 | $125 | $128 | $132 |
| -1.5pp | $127 | $131 | $134 | $138 | $141 |
| +0.0pp | $137 | $140 | $144 | $147 | $151 |
| +1.5pp | $146 | $150 | $154 | $158 | $162 |
| +3.0pp | $156 | $160 | $165 | $169 | $173 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $125 | $165 | $39 |
| Terminal × ±15% | $125 | $162 | $37 |
| Op margin ±3pp | $137 | $151 | $15 |
| WACC ±1pp | $138 | $150 | $13 |
| Capex intensity ±15% | $143 | $145 | $3 |
Company lever — SoP/share vs Semiconductor Equipment multiple (AI re-rating) (base 51x)
| Multiple | 35.7x | 43.4x | 51.0x | 58.6x | 66.3x |
|---|---|---|---|---|---|
| SoP/share | $341 | $415 | $488 | $561 | $635 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $214 (-1% vs spot · street) |
| House target | $250 (+16.7% vs street) |
| Sell-side coverage | 29 analysts (SB 5 / B 13 / H 10 / S 1 / SS 0; net score 0.38) |
| Consensus FY EPS | $5.07; house below (-3.4%) |
| Consensus FY revenue | $17.1B; house below (-17.3%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $1.6B — modestly levered |
| Net debt / EBITDA | 0.27x |
| Interest coverage (EBIT / interest) | 16.4x |
| Current ratio | 2.62x |
| Lease obligations | $0.2B |
| Cash & ST investments | $4.5B |
Balance-sheet data as of 2025-06-30 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $3.7B |
| Buybacks / dividends | $2.1B / $0.9B |
| Total shareholder yield | 1.0% |
| Payout as % of FCF | 81.6% |
| Reinvestment (capex / OCF) | 8.3% |
| SBC as % of FCF | 7.1% |
| Allocation stance | returns-heavy |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 28.6% |
| FCF conversion (FCF / net income) | 92.1% |
| FCF yield | 1.3% |
| Capex intensity (capex / revenue) | 2.6% |
| FCF − SBC (diagnostic) | $3.5B |
| Capex split (maint / growth) | 45% / 55% — Capex history ($0.34B) runs below the forward glidepath (~$0.38-0.54B) because the schedule ramps with the normalised-WFE revenue path - the growth slice (R&D labs, manufacturing/capacity for advanced tools) dominates. Still asset-light vs a fab: capex is only ~4% of revenue, the moat is R&D-intensive not capex-intensive. |
Accounting quality: SBC 2.0% of revenue; cash conversion (OCF/NI) 100% — cash-backed.
Catalyst Calendar
- 2026-06-16 (~-22d) — Investor Day - long-term WFE / process-control-intensity and margin targets (authored)
- 2026-07-30 (~22d) — Quarterly earnings — est. EPS $1.00 (AV EARNINGS_CALENDAR)
- 2026-07-30 (~22d) — Book-to-bill / WFE-order commentary at quarterly call (authored)
- 2026-10-15 (~99d) — US BIS export-control rule update on advanced-node tools to China (authored)
Forecast Track Record
- EPS surprise: beat 100.0% of the last 8 quarters; average surprise +4.5%.
Competitive Moat
Wide moat. KLA's dominant process-control share and installed-base/software lock-in are a genuine wide moat, but a wide moat does not make demand non-cyclical; the falsifiable claim is that ~62x forward prices permanence, so if revenue contracts and non-GAAP operating margin falls below ~51% for two quarters (a WFE down-cycle), the multiple should compress from the mid-50s toward a mid-cyclical ~30x regardless of the moat.
Moat sources:
- ~50%+ share of the process-control / inspection & metrology segment - a dominant, hard-to-displace position at leading-edge nodes
- Installed-base service + software revenue that grows with tools shipped and raises switching costs (calibration, recipes, engineer familiarity)
- Deep leading-edge and advanced-packaging technology lead that widens as process complexity (EUV, gate-all-around, HBM) rises
- NO insulation from the WFE capex cycle - the moat protects share and margin, not the absolute level of demand
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| US / allied export controls on advanced semiconductor tools to China (entity list, sub-14nm rules) | high (~55%) | high - China is a high-30s-to-low-40s % revenue share; a step-tighten is a direct structural demand hit, ~8-12% of FV | 12-24m |
| Chinese retaliation / indigenous-tool substitution accelerating in mature-node process control | medium (~35%) | medium - erodes the China served market over time, ~4-6% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — WFE Reset / China Restriction | A deep WFE reset compounded by tighter China export controls that permanently remove a chunk of addressable demand | Revenue stepping down ~a third with incremental deleverage to low-40s margin while the multiple de-rates to a deep-cyclical trough - target below the 52-week low |
| Cyclical Downturn — Capex Cut | An ordinary capex-digestion air-pocket after two AI-driven years - foundry/logic and memory customers defer tool orders for 1-2 years | Bookings rolling below parity and revenue falling low-double-digits with fixed-cost deleverage giving back ~7 margin points |
| Base — Normalised WFE | Mid-cycle normalised WFE with process-control share intact - high-single-digit revenue growth on a ~55% margin | The ~62x multiple already discounting the upcycle, so normalisation (not re-rating) leaves ~82% of variance (the P/E) exposed |
| Upcycle — Leading-Edge / HBM Capex | Leading-edge and HBM/advanced-packaging capex lifts tool demand above trend with operating leverage | AI-driven leading-edge capex proving front-loaded, setting up a sharper digestion phase afterward |
| Bull — Supercycle Re-Rate | A sustained supercycle where process-control intensity rises structurally with advanced-node and advanced-packaging complexity | Peak-margin, peak-multiple economics being the most mean-reversion-prone point in a cyclical franchise |
What the Market Is Pricing In
At the current price, the market pays 42.7× forward EPS, vs the house DCF terminal 30.0×, and a peer median 47.62×. The house DCF sits 34% below spot, so the market is pricing in more than the house case — roughly 3.7pp of revenue CAGR.
Variant perception: the house view is above-consensus, and the thesis is primarily FCF-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 17.1 | 14.1 | High |
| EPS | 5.1 | 4.9 | Medium |
| Target price | 214.2 | 249.9 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| LRCX | 47.62× | 8% | 35% | direct | 100% |
| AMAT | 49.26× | 8% | 32% | direct | 100% |
| Q | 40.32× | 8% | 23% | direct | 100% |
Quality-weighted forward P/E: 45.7× (simple median 47.62×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (Gordon) (low-confidence cross-check (>50% below median)). Anchor median 224.3. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $83–$270, centre $150 (-31% vs spot); spot sits at the 71th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $199 (-8% vs spot · triangulated FV) |
| Downside to bear case (Structural — WFE Reset / China Restriction) | $70 (-68% vs spot · bear scenario) |
| Reward/risk ratio | 0.1× |
| Margin of safety (FV vs spot) | -9% |
| P(price > spot) — Monte Carlo | 53% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Supercycle Re-Rate): $457.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 10.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 30× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (39.0); Terminal × ±15% (37.0); Op margin ±3pp (15.0); WACC ±1pp (13.0); Capex intensity ±15% (3.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $13.1B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $14.1B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $5.0706 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 1.367B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $1.593B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 10.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 30× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 10%, terminal multiple 30×, FY+5 revenue $18B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Quarterly revenue year-on-year growth < -0.05 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Two consecutive quarters of contracting revenue would confirm the cyclical-downturn path rather than the mid-single-digit base growth, and pull the fair value toward the capex-cut scenario.
- Non-GAAP operating margin < 0.51 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). The base path rests on a 55.4% operating margin; a sustained drop below 51% signals fixed-cost deleverage consistent with the cyclical or structural cases and undercuts the earnings assumption.
- China share of total revenue > 0.42 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). Concentration above the low-40s raises the earnings at risk should export controls tighten further, mapping to the structural-restriction scenario the market is not fully discounting.
- Book-to-bill / bookings commentary direction < 1.0 (2 consecutive prints → Semi Downturn — AI-Capex Digestion / China). A book-to-bill below parity for two quarters is an early confirmation that WFE orders are rolling over ahead of reported revenue, validating the capex-cut mechanism.
- Forward next-quarter revenue guidance midpoint < 3.2 (single event → Semi Downturn — AI-Capex Digestion / China). A guided quarter below roughly $3.2bn breaks the ~$14bn-plus normalised annual run-rate the base target assumes and would force a downward earnings revision.
Fact / Inference / Speculation
- FACT: Spot $216; 52-week range $83–$270; engine rating BUY; base-case target $250 (+15%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $199 (-8% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: BUY
Caution: engine rates BUY on the $250 base case (+15%), but the skeptical triangulation ($199) sits at/below spot — the bull case is largely a multiple bet. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.